138 related articles for article (PubMed ID: 32056202)
1. STIM1 knock-down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton-soluble membrane.
Heo W; Jin N; Park MS; Kim HY; Yoon SM; Lee J; Kim JY
Clin Exp Immunol; 2020 Jun; 200(3):260-271. PubMed ID: 32056202
[TBL] [Abstract][Full Text] [Related]
2. Obinutuzumab: a new class of anti-CD20 monoclonal antibody.
Gagez AL; Cartron G
Curr Opin Oncol; 2014 Sep; 26(5):484-91. PubMed ID: 25014645
[TBL] [Abstract][Full Text] [Related]
3. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.
Debant M; Burgos M; Hemon P; Buscaglia P; Fali T; Melayah S; Le Goux N; Vandier C; Potier-Cartereau M; Pers JO; Tempescul A; Berthou C; Bagacean C; Mignen O; Renaudineau Y
J Immunother Cancer; 2019 Apr; 7(1):111. PubMed ID: 31014395
[TBL] [Abstract][Full Text] [Related]
4. CD20/TNFR1 dual-targeting antibody enhances lysosome rupture-mediated cell death in B cell lymphoma.
Kim JR; Lee D; Kim Y; Kim JY
Cancer Immunol Immunother; 2023 Jun; 72(6):1567-1580. PubMed ID: 36534148
[TBL] [Abstract][Full Text] [Related]
5. Ca
Bhardwaj R; Augustynek BS; Ercan-Herbst E; Kandasamy P; Seedorf M; Peinelt C; Hediger MA
Cell Physiol Biochem; 2020 Mar; 54(2):252-270. PubMed ID: 32176842
[TBL] [Abstract][Full Text] [Related]
6. A STIM1-dependent 'trafficking trap' mechanism regulates Orai1 plasma membrane residence and Ca²⁺ influx levels.
Hodeify R; Selvaraj S; Wen J; Arredouani A; Hubrack S; Dib M; Al-Thani SN; McGraw T; Machaca K
J Cell Sci; 2015 Aug; 128(16):3143-54. PubMed ID: 26116575
[TBL] [Abstract][Full Text] [Related]
7. The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells.
Lee JW; Heo W; Lee J; Jin N; Yoon SM; Park KY; Kim EY; Kim WT; Kim JY
PLoS One; 2018; 13(1):e0191075. PubMed ID: 29324849
[TBL] [Abstract][Full Text] [Related]
8. Interplay between ER Ca
Nelson HA; Leech CA; Kopp RF; Roe MW
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783744
[TBL] [Abstract][Full Text] [Related]
9. Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.
Golay J; Da Roit F; Bologna L; Ferrara C; Leusen JH; Rambaldi A; Klein C; Introna M
Blood; 2013 Nov; 122(20):3482-91. PubMed ID: 24106207
[TBL] [Abstract][Full Text] [Related]
10. Filamin A Modulates Store-Operated Ca
Lopez JJ; Albarrán L; Jardín I; Sanchez-Collado J; Redondo PC; Bermejo N; Bobe R; Smani T; Rosado JA
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):386-397. PubMed ID: 29284605
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between N-terminal and C-terminal domains in stromal interaction molecule 2 (STIM2) determines enhanced STIM2 sensitivity.
Emrich SM; Yoast RE; Xin P; Zhang X; Pathak T; Nwokonko R; Gueguinou MF; Subedi KP; Zhou Y; Ambudkar IS; Hempel N; Machaca K; Gill DL; Trebak M
J Biol Chem; 2019 Apr; 294(16):6318-6332. PubMed ID: 30824535
[TBL] [Abstract][Full Text] [Related]
12. Orai1 and STIM reconstitute store-operated calcium channel function.
Soboloff J; Spassova MA; Tang XD; Hewavitharana T; Xu W; Gill DL
J Biol Chem; 2006 Jul; 281(30):20661-20665. PubMed ID: 16766533
[TBL] [Abstract][Full Text] [Related]
13. Obinutuzumab for the treatment of lymphoproliferative disorders.
Owen C; Stewart DA
Expert Opin Biol Ther; 2012 Mar; 12(3):343-51. PubMed ID: 22283718
[TBL] [Abstract][Full Text] [Related]
14. Fast endocytic recycling determines TRPC1-STIM1 clustering in ER-PM junctions and plasma membrane function of the channel.
de Souza LB; Ong HL; Liu X; Ambudkar IS
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2709-21. PubMed ID: 26232624
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Orai1 and STIM1 expression as well as store-operated Ca
Abdelazeem KNM; Droppova B; Sukkar B; Al-Maghout T; Pelzl L; Zacharopoulou N; Ali Hassan NH; Abdel-Fattah KI; Stournaras C; Lang F
Biochem Biophys Res Commun; 2019 May; 512(3):467-472. PubMed ID: 30902388
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of obinutuzumab for treating chronic lymphocytic leukemia.
Luan C; Chen B
Drug Des Devel Ther; 2019; 13():2899-2909. PubMed ID: 31692500
[TBL] [Abstract][Full Text] [Related]
17. The STIM1: Orai Interaction.
Frischauf I; Fahrner M; Jardín I; Romanin C
Adv Exp Med Biol; 2016; 898():25-46. PubMed ID: 27161223
[TBL] [Abstract][Full Text] [Related]
18. Depletion of the transcriptional coactivators CREB-binding protein or EP300 downregulates CD20 in diffuse large B-cell lymphoma cells and impairs the cytotoxic effects of anti-CD20 antibodies.
Scialdone A; Khazaei S; Hasni MS; Lennartsson A; Gullberg U; Drott K
Exp Hematol; 2019 Nov; 79():35-46.e1. PubMed ID: 31669559
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
